AU3893497A - Multiple emulsions comprising a hydrophobic continuous phase - Google Patents

Multiple emulsions comprising a hydrophobic continuous phase

Info

Publication number
AU3893497A
AU3893497A AU38934/97A AU3893497A AU3893497A AU 3893497 A AU3893497 A AU 3893497A AU 38934/97 A AU38934/97 A AU 38934/97A AU 3893497 A AU3893497 A AU 3893497A AU 3893497 A AU3893497 A AU 3893497A
Authority
AU
Australia
Prior art keywords
continuous phase
multiple emulsions
hydrophobic continuous
hydrophobic
emulsions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38934/97A
Inventor
Marie-Pierre Krafft
Jean G Riess
Leila Zarif
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alliance Pharmaceutical Corp
Original Assignee
Alliance Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alliance Pharmaceutical Corp filed Critical Alliance Pharmaceutical Corp
Publication of AU3893497A publication Critical patent/AU3893497A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
AU38934/97A 1996-08-07 1997-08-06 Multiple emulsions comprising a hydrophobic continuous phase Abandoned AU3893497A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9610140A FR2752161B1 (en) 1996-08-07 1996-08-07 MULTIPLE HYDROCARBON-IN-WATER-IN-FLUOROCARBON EMULSIONS FOR THE TRANSPORT OF HYDROPHILIC AND / OR LIPOPHILIC DRUG SUBSTANCES
FR9610140 1996-08-07
PCT/US1997/013054 WO1998005301A1 (en) 1996-08-07 1997-08-06 Multiple emulsions comprising a hydrophobic continuous phase

Publications (1)

Publication Number Publication Date
AU3893497A true AU3893497A (en) 1998-02-25

Family

ID=9495014

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38934/97A Abandoned AU3893497A (en) 1996-08-07 1997-08-06 Multiple emulsions comprising a hydrophobic continuous phase

Country Status (3)

Country Link
AU (1) AU3893497A (en)
FR (1) FR2752161B1 (en)
WO (1) WO1998005301A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0716992D0 (en) 2007-08-31 2007-10-10 Immune Targeting Systems Its L Influenza antigen delivery vectors and constructs
GB0408164D0 (en) 2004-04-13 2004-05-19 Immune Targeting Systems Ltd Antigen delivery vectors and constructs
CA2788060C (en) 2010-03-17 2017-07-11 Novaliq Gmbh Pharmaceutical composition for treatment of increased intraocular pressure
US9351943B2 (en) * 2010-07-01 2016-05-31 Matthew T. McLeay Anti-fibroblastic fluorochemical emulsion therapies
EP2462921A1 (en) 2010-11-11 2012-06-13 Novaliq GmbH Liquid pharmaceutical compositions for the treatment of a posterior eye disease
CN107397718A (en) 2011-05-25 2017-11-28 诺瓦利克有限责任公司 Externally-applied medicinal composition based on semifluorinated alkane class
KR101989648B1 (en) 2012-01-23 2019-06-14 노바리크 게엠베하 Stabilised protein compositions based on semifluorinated alkanes
EP3181119B1 (en) 2012-09-12 2019-07-10 Novaliq GmbH Semifluorinated alkane compositions for use in the treatment of keratoconjunctivitis sicca
JP6352266B2 (en) 2012-09-12 2018-07-04 ノバリック ゲーエムベーハー Composition comprising a mixture of semi-fluorinated alkanes
BR112016001522B1 (en) 2013-07-23 2019-10-01 Novaliq Gmbh STABILIZED ANTIBODY COMPOSITIONS
ES2803248T3 (en) 2015-09-30 2021-01-25 Novaliq Gmbh 2-perfluorohexyl octane for ophthalmic administration
WO2017055454A1 (en) 2015-09-30 2017-04-06 Novaliq Gmbh Semifluorinated compounds and their compositions
PL3442480T3 (en) 2016-06-23 2020-04-30 Novaliq Gmbh Topical administration method
MX2019003363A (en) 2016-09-22 2019-10-02 Novaliq Gmbh Pharmaceutical compositions for use in the therapy of blepharitis.
EP3515467B1 (en) 2016-09-23 2023-11-29 Novaliq GmbH Ophthalmic compositions comprising ciclosporin
AU2018253944B2 (en) 2017-04-21 2022-09-15 Dermaliq Therapeutics, Inc. Iodine compositions
WO2018206656A1 (en) 2017-05-12 2018-11-15 Novaliq Gmbh Pharmaceutical compositions comprosing semifluorinated alkanes for the treatment of contact lense-related conditions
CN111372566A (en) 2017-09-27 2020-07-03 诺瓦利克有限责任公司 Ophthalmic composition comprising latanoprost for treating ocular diseases
WO2019068763A1 (en) 2017-10-04 2019-04-11 Novaliq Gmbh Ophthalmic compositions comprising f6h8
MX2020009132A (en) 2018-03-02 2020-12-11 Novaliq Gmbh Pharmaceutical compositions comprising nebivolol.
CA3111870C (en) 2018-09-27 2022-04-12 Novaliq Gmbh Topical sunscreen formulation
AU2019358249B2 (en) 2018-10-12 2024-02-22 Novaliq Gmbh Ophthalmic composition for treatment of dry eye disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4206732A1 (en) * 1992-03-04 1993-09-09 Goldschmidt Ag Th LIQUID, STORAGE STABLE, MULTIPLE EMULSION OF THE TYPE O / W / O
DE4405627A1 (en) * 1994-02-22 1995-08-24 Hoechst Ag Oil emulsions containing fluorocarbons
FR2720943B1 (en) * 1994-06-09 1996-08-23 Applic Transferts Technolo Stable inverse emulsions with a high concentration of fluorinated compound (s) and their use for the pulmonary administration of medicaments and for the manufacture of multiple emulsions.
US5770585A (en) * 1995-05-08 1998-06-23 Kaufman; Robert J. Homogeneous water-in-perfluorochemical stable liquid dispersion for administration of a drug to the lung of an animal
US5985177A (en) * 1995-12-14 1999-11-16 Shiseido Co., Ltd. O/W/O type multiple emulsion and method of preparing the same

Also Published As

Publication number Publication date
FR2752161B1 (en) 1998-09-25
FR2752161A1 (en) 1998-02-13
WO1998005301A1 (en) 1998-02-12

Similar Documents

Publication Publication Date Title
AU3893497A (en) Multiple emulsions comprising a hydrophobic continuous phase
AU4008595A (en) Forming emulsions
AU2862095A (en) Sunscreen emulsions
AU6733096A (en) A space element
AU5061796A (en) Phase pipette
AU8891198A (en) High-velocity rudder
AU1886597A (en) A microreactor
AU8546698A (en) Variable phase coupling
AU6735596A (en) Microbicidal 2-phenylethyl-mercapto-triazoles
AU2568097A (en) A field sprayer
AU7430698A (en) Fat emulsions
AU4968996A (en) Razors
AU6738796A (en) Microbicidal mercapto-triazolyl-ketones
AU6738896A (en) Microbicidal mercapto-triazolyl-nitriles
AU6904196A (en) A valvulotome
AUPP108197A0 (en) Stable emulsions
AU4972097A (en) A field controlled resonator
AU1396097A (en) A bio-enhancer
AU5717796A (en) Herbicidal mixtures
AU4313296A (en) Depilatory strips
AU3361597A (en) Electrostatic coalescence
AU6613598A (en) Fuel-water emulsions
AU6313896A (en) Pesticidal compounds
AU4034195A (en) Emulsifier
AU3440197A (en) Fluid-distributor for a substance-exchange-column